The unmasked upstream signaling pathway consisting of PGE2, EP3, Rac1, and PKD may provide a number of new drug target candidates for the treatment of heart failure, in particular of inflammatory cardiomyopathies. This evidence concerns the gene RAC1 and heart failure.